Reliable Biomarkers to Identify New and Recurrent Cancer

Breast cancer is the most frequent cancer detected throughout both the developing and the developed world. Its incidence is on the rise in the developing world. Great strides have been made in developing biomarkers to guide therapy for women diagnosed with breast cancer. Far fewer advances have occu...

Full description

Bibliographic Details
Main Author: Edward R. Sauter
Format: Article
Language:English
Published: Galenos Publishing House 2017-10-01
Series:European Journal of Breast Health
Subjects:
Online Access: http://www.eurjbreasthealth.com/archives/archive-detail/article-preview/reliable-biomarkers-to-dentify-new-and-recurrent-c/42077
_version_ 1797910398389714944
author Edward R. Sauter
author_facet Edward R. Sauter
author_sort Edward R. Sauter
collection DOAJ
description Breast cancer is the most frequent cancer detected throughout both the developing and the developed world. Its incidence is on the rise in the developing world. Great strides have been made in developing biomarkers to guide therapy for women diagnosed with breast cancer. Far fewer advances have occurred with biomarker development for the early diagnosis of breast cancer. Standard screening for new and recurrent breast cancer involves clinical breast exam and breast imaging. There are no Food and Drug Administration (FDA) approved noninvasive body fluid tests for the early detection of new or recurrent breast cancer. Promising biomarker approaches include multianalyte testing of tissue for individuals diagnosed with breast cancer and body fluid analysis for both at risk women and to monitor individuals after treatment.
first_indexed 2024-04-10T11:23:36Z
format Article
id doaj.art-a37d49f20efd4993b491a8d2ca7b5aa4
institution Directory Open Access Journal
issn 2587-0831
language English
last_indexed 2024-04-10T11:23:36Z
publishDate 2017-10-01
publisher Galenos Publishing House
record_format Article
series European Journal of Breast Health
spelling doaj.art-a37d49f20efd4993b491a8d2ca7b5aa42023-02-15T16:18:31ZengGalenos Publishing HouseEuropean Journal of Breast Health2587-08312017-10-0113416216710.5152/ejbh.2017.363513049054Reliable Biomarkers to Identify New and Recurrent CancerEdward R. Sauter0 Department of Surgery, Hartford Hospital and University of Connecticut School of Medicine, Hartford, USA Breast cancer is the most frequent cancer detected throughout both the developing and the developed world. Its incidence is on the rise in the developing world. Great strides have been made in developing biomarkers to guide therapy for women diagnosed with breast cancer. Far fewer advances have occurred with biomarker development for the early diagnosis of breast cancer. Standard screening for new and recurrent breast cancer involves clinical breast exam and breast imaging. There are no Food and Drug Administration (FDA) approved noninvasive body fluid tests for the early detection of new or recurrent breast cancer. Promising biomarker approaches include multianalyte testing of tissue for individuals diagnosed with breast cancer and body fluid analysis for both at risk women and to monitor individuals after treatment. http://www.eurjbreasthealth.com/archives/archive-detail/article-preview/reliable-biomarkers-to-dentify-new-and-recurrent-c/42077 breast cancerbiomarkerscarbohydratesproteinslipids
spellingShingle Edward R. Sauter
Reliable Biomarkers to Identify New and Recurrent Cancer
European Journal of Breast Health
breast cancer
biomarkers
carbohydrates
proteins
lipids
title Reliable Biomarkers to Identify New and Recurrent Cancer
title_full Reliable Biomarkers to Identify New and Recurrent Cancer
title_fullStr Reliable Biomarkers to Identify New and Recurrent Cancer
title_full_unstemmed Reliable Biomarkers to Identify New and Recurrent Cancer
title_short Reliable Biomarkers to Identify New and Recurrent Cancer
title_sort reliable biomarkers to identify new and recurrent cancer
topic breast cancer
biomarkers
carbohydrates
proteins
lipids
url http://www.eurjbreasthealth.com/archives/archive-detail/article-preview/reliable-biomarkers-to-dentify-new-and-recurrent-c/42077
work_keys_str_mv AT edwardrsauter reliablebiomarkerstoidentifynewandrecurrentcancer